Washington Homeopathic Cinnamomum Pills Recalled for Failed Identity Testing
Washington Homeopathic Products is recalling Cinnamomum 6X and 30X homeopathic pills due to failed identification testing results. The products did not meet specifications in HPTLC analysis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving homeopathic products with failed identity testing. No illnesses, injuries, or deaths are reported in the source text. The hazard is a labeling/quality-specification issue rather than a direct safety threat, placing this in the Moderate category.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Cinnamomum 6X and Cinnamomum 30X homeopathic flatulence pills packaged in 4 Dram and 1 oz bottles. The recall affects lot #28626 with expiration date 8/17/2026, distributed nationwide in the USA.
The products are being recalled because identification testing based on HPTLC (High Performance Thin Layer Chromatography) analysis yielded out-of-specification results. The products did not meet required identity specifications.
Consumers who have purchased these products should discontinue use and contact Washington Homeopathic Products for further instructions.
The recalled product
- Product
- Cinnamomum 6X, Flatulence* Sucrose/Lactose Pills, Packaged as a) 4 Dram, b) 1 oz, and Cinnamomum 30X, Flatulence* Sucrose/Lactose Pills, Packaged as 4 Dram, WHP Homeopathic Medicine, Washington Homeopathic Products 260 JR Hawvermale Way, Berkeley Springs WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- failed-identity-testing
- out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 28626
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27